Please use this identifier to cite or link to this item:
Title: Multidisciplinary supportive care for improving survival and quality of life in motor neuron disease
Authors: Georgiou, Anastasios M. 
Keywords: Evidence based practice;MND care;Motor neuron disease;Multidisciplinary care
Category: Clinical Medicine
Field: Medical and Health Sciences
Issue Date: Jan-2018
Source: International Journal on Disability and Human Development, 2018, Volume 17, Issue 4, Pages 439-444
Journal: International Journal on Disability and Human Development 
Abstract: Motor neuron disease (MND) is a progressive and fatal neurological condition. Riluzole is the only pharmacological agent that is currently prescribed for all MND types. It is currently suggested that a 100 mg daily dose is safe and probably prolongs median MND survival by about 2-3 months. There is evidence that multidisciplinary teams (MDTs) contribute to symptoms relief, QoL improvement and increases in survival rates in patients suffering from MND. As respiratory, nutritional and swallowing problems are amongst the most important factors that are associated with decreased QoL and shorter survival, a large and growing body of literature has been investigating the best evidence for respiratory and nutritional support in MND care.
ISSN: 2191-0367
Rights: © Nova Science Publishers, Inc.
Type: Article
Appears in Collections:Άρθρα/Articles

Show full item record

Page view(s)

Last Week
Last month
checked on Oct 15, 2019

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.